Clinical trials
Hepatitis B trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 6 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
| Unknown status | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 33 |
| Hasselt University | 4 |
| Henogen | 4 |
| Gilead Sciences | 2 |
| VBI Vaccines Inc. | 2 |
| IDEWE Occupational Health Services | 1 |
| Janssen Research & Development, LLC | 1 |
| Janssen Sciences Ireland UC | 1 |
| Maastricht University Medical Center | 1 |
| Novosanis NV | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B | 52 |
| Hepatitis A | 11 |
| Hepatitis C | 4 |
| Acquired Immunodeficiency Syndrome | 3 |
| Hepatitis B, Chronic | 3 |
| End Stage Liver Disease | 2 |
| HIV Infections | 2 |
| Liver Diseases | 2 |
| Acidosis, Lactic | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 76 to 52 of 52. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.